Author: Arunachalam, Prabhu S.; Wimmers, Florian; Mok, Chris Ka Pun; Perera, Ranawaka A. P. M.; Scott, Madeleine; Hagan, Thomas; Sigal, Natalia; Feng, Yupeng; Bristow, Laurel; Tak-Yin Tsang, Owen; Wagh, Dhananjay; Coller, John; Pellegrini, Kathryn L.; Kazmin, Dmitri; Alaaeddine, Ghina; Leung, Wai Shing; Chan, Jacky Man Chun; Chik, Thomas Shiu Hong; Choi, Chris Yau Chung; Huerta, Christopher; Paine McCullough, Michele; Lv, Huibin; Anderson, Evan; Edupuganti, Srilatha; Upadhyay, Amit A.; Bosinger, Steve E.; Maecker, Holden Terry; Khatri, Purvesh; Rouphael, Nadine; Peiris, Malik; Pulendran, Bali
Title: Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans Cord-id: spvp7bwz Document date: 2020_9_4
ID: spvp7bwz
Snippet: Coronavirus disease 2019 (COVID-19) represents a global crisis, yet major knowledge gaps remain about human immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We analyzed immune responses in 76 COVID-19 patients and 69 healthy individuals from Hong Kong and Atlanta, Georgia, United States. In the peripheral blood mononuclear cells (PBMCs) of COVID-19 patients, we observed reduced expression of human leukocyte antigen class DR (HLA-DR) and proinflammatory cytokines by myelo
Document: Coronavirus disease 2019 (COVID-19) represents a global crisis, yet major knowledge gaps remain about human immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We analyzed immune responses in 76 COVID-19 patients and 69 healthy individuals from Hong Kong and Atlanta, Georgia, United States. In the peripheral blood mononuclear cells (PBMCs) of COVID-19 patients, we observed reduced expression of human leukocyte antigen class DR (HLA-DR) and proinflammatory cytokines by myeloid cells as well as impaired mammalian target of rapamycin (mTOR) signaling and interferon-α (IFN-α) production by plasmacytoid dendritic cells. By contrast, we detected enhanced plasma levels of inflammatory mediators—including EN-RAGE, TNFSF14, and oncostatin M—which correlated with disease severity and increased bacterial products in plasma. Single-cell transcriptomics revealed a lack of type I IFNs, reduced HLA-DR in the myeloid cells of patients with severe COVID-19, and transient expression of IFN-stimulated genes. This was consistent with bulk PBMC transcriptomics and transient, low IFN-α levels in plasma during infection. These results reveal mechanisms and potential therapeutic targets for COVID-19.
Search related documents:
Co phrase search for related documents- accession number and lung disease: 1
- activator signal transducer and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- activator signal transducer and adaptive innate: 1, 2, 3, 4
- activator signal transducer and lps lipopolysaccharide: 1, 2, 3, 4, 5
- activator signal transducer and lung alveolar cell: 1
- activator signal transducer and lung disease: 1, 2, 3, 4, 5
- activator signal transducer and lung fibroblast: 1
- acute ards respiratory disease syndrome and adaptive innate: 1, 2, 3, 4
- acute ards respiratory disease syndrome and low quality: 1, 2
- acute ards respiratory disease syndrome and lps lipopolysaccharide: 1, 2, 3
- acute ards respiratory disease syndrome and lung alveolar cell: 1, 2
- acute ards respiratory disease syndrome and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and adaptive innate immune cell: 1, 2, 3, 4, 5, 6, 7
- acute respiratory syndrome and low quality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and lps lipopolysaccharide: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and lung alveolar cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- acute respiratory syndrome and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and lung express: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date